ダウンロード数: 390
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 25_1333.pdf | 625.38 kB | Adobe PDF | 見る/開く |
| タイトル: | 前立腺肥大症の薬物療法 |
| その他のタイトル: | MEDICAL TREATMENT IN BENIGN PROSTATIC HYPERTROPHY |
| 著者: | 片山, 喬  島崎, 淳 真田, 寿彦 大塚, 薫 載, 東風 |
| 著者名の別形: | Katayama, Takashi Shimazaki, Jun Sanada, Toshihiko Otsuka, Kaoru Tai, Tohfun |
| 発行日: | Dec-1979 |
| 出版者: | 京都大学医学部泌尿器科学教室 |
| 誌名: | 泌尿器科紀要 |
| 巻: | 25 |
| 号: | 12 |
| 開始ページ: | 1333 |
| 終了ページ: | 1341 |
| 抄録: | Comparative study of 7 drugs was carried out in patients with benign prostatic hypertrophy. The 7 drugs were chlormadinone acetate (CMA), TSAA-291, medroxy-progesterone acetate (MPA), allylestrenol (AE), polyene macrolide (Levorin, PM), Paraprost (PPC) and Eviprostat (EP). Its clinical evaluation was made by subjective symptoms, measurement of residual urine, rectal palpation of the prostate and urethrography. PM was effective to the improvement of subjective symptoms and all evaluated items. Judging from the degree of lowering of bladder base in urethrography, improvement in CMA group was significantly better than that in other 7 groups. Literatures regarding the medical treatment in benign prostatic hypertrophy were reviewed. |
| URI: | http://hdl.handle.net/2433/122551 |
| 出現コレクション: | Vol.25 No.12 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。